Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with theTopical Endolysin Staphefekt SA.100: A Report of 3 Cases

Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with theTopical Endolysin Staphefekt SA.100: A Report of 3 Cases

This publication describes 3 cases where patients with chronic and recurrent S. aureus-related dermatoses were successfully treated with Staphefekt SA.100, the active ingredient of Gladskin. The results indicate that targeted treatment with Staphefekt might be an attractive alternative for (long-term) classical antibiotic therapy.

Read the article

Share this article

Bekijk een volgend artikel

Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis
Shopping Cart
×

Total-

Subtotal